New search | Conferencedetail
Print view
 
 

Treg Directed Therapy for Autoimmune Disorders Summit 2018

evvnt Platform / evvnt
-
22.05.2018 - 24.05.2018  Westin Boston Waterfront, 425 Summer Street, 02210 Boston, USA
8:00 am to 4:00 pm
 
Conference themes
This is your first and only opportunity to listen to the most advanced clinical case studies from Nektar Therapeutics and Amgen which explore the use of IL-2 to enhance the expansion and activation of the Treg cells. Delve deeper with expert insights from Roche and ILTOO Pharma to understand how IL-2 at low doses could selectively stimulate Treg cells.
URLs: Brochure:https://go.evvnt.com/197029-1?pid=4832
Inquiries: https://go.evvnt.com/197029-2?pid=4832
Professional congress organizer (PCO)
Hanson Wade
Notes
Chris Haqq, Kevin Gorski, Nadia Tchao, David Wraith, Andrew Scharenberg, Simrit Parmar, Robert Plenge, Stephen Miller, Todd Brusko, Jeremie Mariau, Laurence Turka, Jason Fontenot, Leonard Dragone
 

Enquiries and Registration:

https://go.evvnt.com/197029-0?pid=4832
Ms. Georgina FitzGerald
 
Categories
Internal Medicine
Languages
English
Congress fees
USD 499,00
(Conference Only (Earlybird ends Feb 23): USD 1999, Conference Only (Earlybird ends Mar 23): USD 2199,Conference Only: USD 2799,Workshop Only: USD 499)
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
Tel: +44 0207 3230 450
hello@evvnt.com
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Österreichisches Rotes KreuzHilfswerk AustrianewTreeSwiss Tropical and Public Health InstituteEuropean Health Forum GasteinAMREF - African Medical and Research FoundationEuropean Public Health Association (EUPHA)Anästhesie in Entwicklungsländern e. V.

Facebook

Give us your professional opinion

Start survey

Start survey